1 - 25 of 117 results for author:"Acharya K.R." in Literature citations
Results Customize
› Repeat search in UniProtKB (52)
| Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogaster. Akif M., Masuyer G., Bingham R.J., Sturrock E.D., Isaac R.E., Acharya K.R. FEBS J. 279:4525-4534(2012) · Mapped (4) |
| Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides. Masuyer G., Schwager S.L., Sturrock E.D., Isaac R.E., Acharya K.R. Sci Rep 2:717-717(2012) · Mapped (3) |
| Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons. Thiyagarajan N., Ferguson R., Subramanian V., Acharya K.R. Nat Commun 3:1121-1121(2012) · Mapped (1) |
| Structures of engineered Clostridium botulinum neurotoxin derivatives. Masuyer G., Stancombe P., Chaddock J.A., Acharya K.R. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 67:1466-1472(2011) · Mapped (2) |
| Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor. Masuyer G., Jabeen T., Oberg C.T., Leffler H., Nilsson U.J., Acharya K.R. FEBS J. 279:193-202(2012) · Mapped (1) |
| Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril. Akif M., Masuyer G., Schwager S.L., Bhuyan B.J., Mugesh G., Isaac R.E., Sturrock E.D., Acharya K.R. FEBS J. 278:3644-3650(2011) · Mapped (2) |
| Molecular recognition of chymotrypsin by the serine protease inhibitor ecotin from Yersinia pestis. Clark E.A., Walker N., Ford D.C., Cooper I.A., Oyston P.C., Acharya K.R. J. Biol. Chem. 286:24015-24022(2011) · Mapped (2) |
| Cloning, purification, crystallization and preliminary crystallographic analysis of the human histone deacetylase sirtuin 1. Holbourn K.P., Lloyd M.D., Thompson A.S., Threadgill M.D., Acharya K.R. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 67:461-463(2011) · Mapped (6) |
| Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide. Akif M., Schwager S.L., Anthony C.S., Czarny B., Beau F., Dive V., Sturrock E.D., Acharya K.R. Biochem. J. 436:53-59(2011) · Mapped (1) |
| Functional and structural analyses of N-acylsulfonamide-linked dinucleoside inhibitors of RNase A. Thiyagarajan N., Smith B.D., Raines R.T., Acharya K.R. FEBS J. 278:541-549(2011) · Mapped (1) |
| Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B. Masuyer G., Beard M., Cadd V.A., Chaddock J.A., Acharya K.R. J. Struct. Biol. 174:52-57(2011) · Mapped (1) |
| The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407. Anthony C.S., Corradi H.R., Schwager S.L., Redelinghuys P., Georgiadis D., Dive V., Acharya K.R., Sturrock E.D. J. Biol. Chem. 285:35685-35693(2010) · Mapped (1) |
| Crystal structure of a phosphonotripeptide K-26 in complex with angiotensin converting enzyme homologue (AnCE) from Drosophila melanogaster. Akif M., Ntai I., Sturrock E.D., Isaac R.E., Bachmann B.O., Acharya K.R. Biochem. Biophys. Res. Commun. 398:532-536(2010) · Mapped (1) |
| Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity. Iyer S., Darley P.I., Acharya K.R. J. Biol. Chem. 285:23779-23789(2010) · UniProtKB (1) · Mapped (12) |
| High-resolution crystal structures of Drosophila melanogaster angiotensin-converting enzyme in complex with novel inhibitors and antihypertensive drugs. Akif M., Georgiadis D., Mahajan A., Dive V., Sturrock E.D., Isaac R.E., Acharya K.R. J. Mol. Biol. 400:502-517(2010) · Mapped (1) |
| Chimeric microtubule disruptors. Leese M.P., Jourdan F., Kimberley M.R., Cozier G.E., Thiyagarajan N., Stengel C., Regis-Lydi S., Foster P.A., Newman S.P., Acharya K.R. et al. Chem. Commun. (Camb.) 46:2907-2909(2010) · Mapped (1) |
| Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors. Cozier G.E., Leese M.P., Lloyd M.D., Baker M.D., Thiyagarajan N., Acharya K.R., Potter B.V. Biochemistry 49:3464-3476(2010) · Mapped (2) |
| Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template. Woo L.W., Jackson T., Putey A., Cozier G., Leonard P., Acharya K.R., Chander S.K., Purohit A., Reed M.J., Potter B.V. J. Med. Chem. 53:2155-2170(2010) · Mapped (1) |
| Structural basis for substrate recognition in the enzymatic component of ADP-ribosyltransferase toxin CDTa from Clostridium difficile. Sundriyal A., Roberts A.K., Shone C.C., Acharya K.R. J. Biol. Chem. 284:28713-28719(2009) · UniProtKB (1) |
| Structures of native human thymidine phosphorylase and in complex with 5-iodouracil. Mitsiki E., Papageorgiou A.C., Iyer S., Thiyagarajan N., Prior S.H., Sleep D., Finnis C., Acharya K.R. Biochem. Biophys. Res. Commun. 386:666-670(2009) · UniProtKB (1) · Mapped (4) |
| Crystal structure of alpha-1,3-galactosyltransferase (alpha3GT) in a complex with p-nitrophenyl-beta-galactoside (pNPbetaGal). Jamaluddin H., Tumbale P., Ferns T.A., Thiyagarajan N., Brew K., Acharya K.R. Biochem. Biophys. Res. Commun. 385:601-604(2009) · Mapped (1) |
| Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A. Masuyer G., Thiyagarajan N., James P.L., Marks P.M., Chaddock J.A., Acharya K.R. Biochem. Biophys. Res. Commun. 381:50-53(2009) · Mapped (2) |
| Influence of naturally-occurring 5'-pyrophosphate-linked substituents on the binding of adenylic inhibitors to ribonuclease a: an X-ray crystallographic study. Holloway D.E., Chavali G.B., Leonidas D.D., Baker M.D., Acharya K.R. Biopolymers 91:995-1008(2009) · Mapped (1) |
| Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragment. Leonard P., Scotney P.D., Jabeen T., Iyer S., Fabri L.J., Nash A.D., Acharya K.R. J. Mol. Biol. 384:1203-1217(2008) · Mapped (7) |
| Screening a limited structure-based library identifies UDP-GalNAc-specific mutants of alpha-1,3-galactosyltransferase. Tumbale P., Jamaluddin H., Thiyagarajan N., Acharya K.R., Brew K. Glycobiology 18:1036-1043(2008) · Mapped (1) |